Viewing Study NCT05457933


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-01-15 @ 9:06 PM
Study NCT ID: NCT05457933
Status: COMPLETED
Last Update Posted: 2023-10-19
First Post: 2022-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes
Sponsor: Medanta, The Medicity, India
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module